17 April, 2018 Resources

Pharma: a tale of rising demand and squeezed prices

Download the Document

Pharmaceuticals Sector Risk Report

Overview

Spending on prescription drugs is on an upward trajectory worldwide, and especially in Western Europe and the US. Pharma group profits rose by 2.9% in 2017. Reasons include ageing populations, changing lifestyles and pressure to access innovative treatments, and the rise comes despite the efforts of governments to control healthcare spending. The US situation is particularly uncertain, with the Trump administration’s attempts to repeal ‘Obamacare’ meeting difficulties.

 

Coface Regional Sector Risk Assessment

Strengths and weaknesses

Coface analysts predict research and development by pharmaceutical companies to pick up in 2018, and for prescription sales to grow – by 4% France, UK, Germany, Italy and Spain for example. This is driven by the rise in specialist drugs, which now amount to over a third of the total. Everywhere pharmaceutical companies are under pressure to provide discounts and lower prices by governments facing increasing demand. In the US alone, health insurance costs are likely to rise by as much as 18% in 2018.

Throughout the world healthcare provision is in flux and prices are being driven down. That’s why any company dealing with the pharma sector needs to have the best business data and insight on tap. It all comes free when you’re a Coface credit insurance policy holder.

Want to know how Coface can help your business know more and grow more?

Get in touch About us

Related resources

Resources

Grow your business safely

Focus on sustainable growth. This is indisputably a tough time for business. Experts believe it will take years for the economy to recover from the shock of the pandemic and lockdown while there is continued uncertainty

02 December, 2020

View Resource
Resources

ExpressECO

The COVID-19 pandemic has contributed to a unique set of circumstances weighing on the world economy, notably in terms of political risk. Julien Marcilly, Coface’s Chief Economist, presents some of our predictions for 2021,

27 November, 2020

View Resource
Resources

Country & Sector Risk Barometer: Q3 2020 Quarterly Update

Similar to last quarter, the uncertainties surrounding the forecasts presented in this barometer are very high. They are primarily linked to the global health situation: since June, the pandemic has continued to gain momentum.

01 October, 2020

View Resource

SEE OUR NEWS HUB FOR MORE INFO

Keep your finger on the pulse with CofaNews

Sign up to CofaNews for the latest industry and economic news, exclusive invites and lots more.